Indications
Therapeutic Asset Ratings
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Fludarabine
Chronic Myeloid Leukemia
Ohio State University Comprehensive Cancer Center
P3
BB
(69)
Fluorouracilum
Anal Carcinoma
Federation Francophone de Cancerologie Digestive
P3
BB
(69)
Fluorouracilum
Gastroesophageal Junction Adenocarcinoma
Alliance for Clinical Trials in Oncology
P3
BB
(69)
Fluorouracilum
Metastatic Malignant Neoplasm
I-Mab Biopharma US Limited
P3
BB
(69)
Ibrutinib
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
The First Affiliated Hospital with Nanjing Medical University
P3
BB
(69)
Idarubicin
Acute Myeloid Leukemia By FAB Classification
University of Nebraska
P3
BB
(69)
Ipilimumab
Metastatic Neoplasm
7 Hills Pharma, LLC
P3
BB
(69)
Irinotecan
Colon Carcinoma
SCRI Development Innovations, LLC
P3
BB
(69)
Irinotecan
Fallopian Tube Cancer
Tianjin Medical University Cancer Institute and Hospital
P3
BB
(69)
Irinotecan
Glioblastoma
University of Cincinnati
P3
BB
(69)
Irinotecan
Lung Cancer
City of Hope Medical Center
P3
BB
(69)
Isocyclophosphamide
High Grade B-Cell Lymphoma
University of California, Davis
P3
BB
(69)
Lenalidomide
Plasma Cell Neoplasm
Hellenic Society of Hematology
P3
BB
(69)
Lenvatinib
Non-Small Cell Lung Carcinoma
Sun Yat-sen University
P3
BB
(69)
Levofolinic Acid
Colorectal Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
P3
BB
(69)
Mercaptopurine Anhydrous
B-Cell Acute Lymphoblastic Leukemia
SWOG Cancer Research Network
P3
BB
(69)
Methotrexate
Leukemia
Dana-Farber Cancer Institute
P3
BB
(69)
Methotrexate
Myelodysplastic Syndrome
The First Affiliated Hospital of Soochow University
P3
BB
(69)
Mitoxantrone
Leukemia
University of Colorado, Denver
P3
BB
(69)
Mitoxantrone
Lymphoma
First Affiliated Hospital Xi'an Jiaotong University
P3
BB
(69)
Nilutamide
Prostate Adenocarcinoma
SWOG Cancer Research Network
P3
BB
(69)
Nivestim
Acute Myeloid Leukemia With 11q23 Abnormalities
M.D. Anderson Cancer Center
P3
BB
(69)
Olaparib
Fallopian Tube Serous Adenocarcinoma
NRG Oncology
P3
BB
(69)
Orelabrutinib
Primary Central Nervous System Lymphoma
The First Affiliated Hospital with Nanjing Medical University
P3
BB
(69)
Orforglipron
Obesity Disorder
Eli Lilly and Company
P3
BB
(69)
Showing 1226 to 1250 of 42,301 assets
Previous
Page 50 of 1693
Next